Argatroban is a medication used to prevent blood clots from forming in the bloodstream. In this study, it is being tested to see how well it works to keep blood flowing smoothly while a patient is receiving specialized breathing and heart support.

Enoxaparin is a type of medicine that thins the blood to help prevent dangerous blood clots. This study investigates its use in helping patients stay safe from clotting while they are on life support machines.

Heart failure – This condition occurs when the heart muscle cannot pump blood as effectively as it should to meet the body’s needs. It often develops gradually as the heart becomes weakened or stiff over time. As the condition progresses, the heart may struggle to circulate enough oxygen-rich blood to vital organs. This can lead to a buildup of fluid in the lungs and other parts of the body. The severity can increase as the heart works harder to compensate for its reduced pumping capacity.

Lung failure – This condition happens when the lungs can no longer perform their essential function of transferring oxygen into the blood and removing carbon dioxide. It can result from various underlying issues that damage the lung tissue or the air sacs. As the disease advances, the levels of oxygen in the bloodstream may drop significantly. This progression often leads to increased difficulty in breathing and impaired gas exchange. Over time, the respiratory system becomes increasingly unable to support the body’s metabolic requirements.